Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

Author

  • Charles Vogel
2020

A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer

The Breast Cancer Therapy Expert Group (BCTEG), Jan 1 2020, (Accepted/In press) In : Clinical breast cancer.

Research output: Contribution to journalReview article

1 Scopus citations

Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)

Kittaneh, M., Badve, S., Caldera, H., Coleman, R., Goetz, M. P., Mahtani, R., Mamounas, E., Kalinsky, K., Lower, E., Pegram, M., Press, M. F., Rugo, H. S., Schwartzberg, L., Traina, T. & Vogel, C., Jan 1 2020, (Accepted/In press) In : Clinical breast cancer.

Research output: Contribution to journalReview article

Open Access
2019
1 Scopus citations
3 Scopus citations
2016

A non-randomized dose-escalation phase i trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors

Limentani, S. A., Csampone, M., Dorval, T., Curigliano, G., de Boer, R., Vogel, C., White, S., Bachelot, T., Canon, J. L., Disis, M., Awada, A., Berlière, M., Amant, F., Levine, E., Burny, W., Callegaro, A., De Sousa Alves, P. M., Louahed, J., Brichard, V. & Lehmann, F. F., Jan 1 2016, In : Breast cancer research and treatment. 156, 2, p. 319-330 12 p.

Research output: Contribution to journalArticle

18 Scopus citations

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

Michiels, S., Pugliano, L., Marguet, S., Grun, D., Barinoff, J., Cameron, D., Cobleigh, M., Di Leo, A., Johnston, S., Gasparini, G., Kaufman, B., Marty, M., Nekljudova, V., Paluch-Shimon, S., Penault-Llorca, F., Slamon, D., Vogel, C., von Minckwitz, G., Buyse, M. & Piccart, M., Jun 18 2016, In : Annals of Oncology. 27, 6, p. 1029-1034 6 p.

Research output: Contribution to journalArticle

19 Scopus citations

When can a salvage therapy (T-DM1) take the lead?

Mahtani, R. & Vogel, C., Oct 10 2016, In : Journal of Clinical Oncology. 34, 29, p. 3492-3494 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2015

Defining the survival benchmark for breast cancer patients with systemic relapse

Zeichner, S. B., Ambros, T., Zaravinos, J., Montero, A. J., Mahtani, R. L., Ahn, E. R., Mani, A., Markward, N. J. & Vogel, C. L., Feb 12 2015, In : Breast Cancer: Basic and Clinical Research. 9, p. 9-17 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature

Zeichner, S. B., Herna, S., Mani, A., Ambros, T., Montero, A. J., Mahtani, R., Ahn, E. R. & Vogel, C., Sep 10 2015, In : Breast Cancer Research and Treatment. 153, 3, p. 617-624 8 p.

Research output: Contribution to journalArticle

21 Scopus citations
2014

A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer

Ambros, T., Zeichner, S. B., Zaravinos, J., Montero, A. J., Ahn, E. R., Aruna, M., Kronish, L., Mahtani, R. L. & Vogel, C. L., Jul 2014, In : Breast cancer research and treatment. 146, 1, p. 7-14 8 p.

Research output: Contribution to journalReview article

9 Scopus citations

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

Kaufman, P. A., Bloom, K. J., Burris, H., Gralow, J. R., Mayer, M., Pegram, M., Rugo, H. S., Swain, S. M., Yardley, D. A., Chau, M., Lalla, D., Yoo, B., Brammer, M. G. & Vogel, C. L., Sep 1 2014, In : Cancer. 120, 17, p. 2657-2664 8 p.

Research output: Contribution to journalArticle

27 Scopus citations

Toremifene for breast cancer: A review of 20 years of data

Vogel, C. L., Johnston, M. A., Capers, C. & Braccia, D., Feb 2014, In : Clinical breast cancer. 14, 1, p. 1-9 9 p.

Research output: Contribution to journalReview article

31 Scopus citations
2013

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

Mackey, J. R., Martin, M., Pienkowski, T., Rolski, J., Guastalla, J. P., Sami, A., Glaspy, J., Juhos, E., Wardley, A., Fornander, T., Hainsworth, J., Coleman, R., Modiano, M. R., Vinholes, J., Pinter, T., Rodríguez-Lescure, Á., Colwell, B., Whitlock, P., Provencher, L., Laing, K. & 10 others, Walde, D., Price, C., Hugh, J. C., Childs, B. H., Bassi, K., Lindsay, M. A., Wilson, V., Rupin, M., Houé, V. & Vogel, C., Jan 1 2013, In : The Lancet Oncology. 14, 1, p. 72-80 9 p.

Research output: Contribution to journalArticle

128 Scopus citations

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: A randomized Phase II study comparing the incidence of peripheral neuropathy

Vahdat, L. T., Garcia, A. A., Vogel, C., Pellegrino, C., Lindquist, D. L., Iannotti, N., Gopalakrishna, P. & Sparano, J. A., Jul 1 2013, In : Breast cancer research and treatment. 140, 2, p. 341-351 11 p.

Research output: Contribution to journalArticle

38 Scopus citations

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: A pooled analysis

Pajares, B., Pollán, M., Martín, M., Mackey, J. R., Lluch, A., Gavila, J., Vogel, C., Ruiz-Borrego, M., Calvo, L., Pienkowski, T., Rodríguez-Lescure, Á., Seguí, M. A., Tredan, O., Antón, A., Ramos, M., Cámara, M. D. C., Rodríguez-Martín, C., Carrasco, E. & Alba, E., Nov 6 2013, In : Breast Cancer Research. 15, 6, R105.

Research output: Contribution to journalArticle

32 Scopus citations
2012

Bevacizumab in the treatment of metastatic breast cancer: Friend or foe?

Montero, A. J., Escobar, M., Lopes, G., Glück, S. & Vogel, C., Feb 2012, In : Current oncology reports. 14, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

48 Scopus citations

Bone-related complications and quality of life in advanced breast cancer: Results from a randomized phase III trial of denosumab versus zoledronic acid

Martin, M., Bell, R., Bourgeois, H., Brufsky, A., Diel, I., Eniu, A., Fallowfield, L., Fujiwara, Y., Jassem, J., Paterson, A. H. G., Ritchie, D., Steger, G. G., Stopeck, A., Vogel, C., Fan, M., Jiang, Q., Chung, K., Dansey, R. & Braun, A., Sep 1 2012, In : Clinical Cancer Research. 18, 17, p. 4841-4849 9 p.

Research output: Contribution to journalArticle

67 Scopus citations

Clinical pharmacology of trastuzumab emtansine (T-DM1): An antibody-drug conjugate in development for the treatment of HER2-positive cancer

Girish, S., Gupta, M., Wang, B., Lu, D., Krop, I. E., Vogel, C. L., Burris, H. A., LoRusso, P. M., Yi, J. H., Saad, O., Tong, B., Chu, Y. W., Holden, S. & Joshi, A., May 1 2012, In : Cancer Chemotherapy And Pharmacology. 69, 5, p. 1229-1240 12 p.

Research output: Contribution to journalArticle

169 Scopus citations

Commentary

Vogel, C. L., Feb 1 2012, In : Clinical Advances in Hematology and Oncology. 10, 2, p. 18-23 6 p.

Research output: Contribution to journalArticle

Dual HER2-targeted approaches in HER2-positive breast cancer

Ahn, E. R. & Vogel, C. L., Jan 1 2012, In : Breast cancer research and treatment. 131, 2, p. 371-383 13 p.

Research output: Contribution to journalReview article

40 Scopus citations

Fighting fire with fire: Rekindling the bevacizumab debate

Montero, A. J. & Vogel, C., Jan 26 2012, In : New England Journal of Medicine. 366, 4, p. 374-375 2 p.

Research output: Contribution to journalEditorial

27 Scopus citations

Final 5-year results of Z-FAST trial: Adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole

Brufsky, A. M., Harker, W. G., Beck, J. T., Bosserman, L., Vogel, C., Seidler, C., Jin, L., Warsi, G., Argonza-Aviles, E., Hohneker, J., Ericson, S. G. & Perez, E. A., Mar 1 2012, In : Cancer. 118, 5, p. 1192-1201 10 p.

Research output: Contribution to journalReview article

121 Scopus citations

Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer

Buzdar, A., Vogel, C., Schwartzberg, L., Garin, A., Perez, A., Ingle, J., Houghton, M., Zergebel, C. & Kimball, B., Jul 1 2012, In : Cancer. 118, 13, p. 3244-3253 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

The editorialists reply

Montero, A. J. & Vogel, C. L., Apr 26 2012, In : New England Journal of Medicine. 366, 17, 1 p.

Research output: Contribution to journalLetter